Hydra Medical Investments, L.L.C. – Trademark Portfolio
Entity Type: 16
Hydra Medical Investments, L.L.C. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HYDRA MEDICAL. The owner is based in Fort Worth, TX.
4609 Boulder Run
Fort Worth, TX 76109
Showing of trademarks Trademarks
Trademark Classifications
Hydra Medical Investments, L.L.C.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Hydra Medical Investments, L.L.C. have?
Hydra Medical Investments, L.L.C. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Hydra Medical Investments, L.L.C. file in?
Hydra Medical Investments, L.L.C. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 39 (Transportation & Storage). Class 35 covers advertising; business management; business administration; office functions.
What are Hydra Medical Investments, L.L.C.'s most well-known trademarks?
Hydra Medical Investments, L.L.C.'s registered trademark portfolio includes well-known marks such as HYDRA MEDICAL. These are among 1 currently registered trademark in the portfolio.
What is Hydra Medical Investments, L.L.C.'s trademark registration success rate?
Hydra Medical Investments, L.L.C. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.